HMB-Val-Ser-Leu-VE, with the CAS number 862891-04-1, is a synthetic peptide that is a derivative of β-hydroxy β-methylbutyrate (HMB), which is known for its role in muscle metabolism and recovery. This compound is characterized by its specific amino acid sequence, which includes valine (Val), serine (Ser), leucine (Leu), and a variant of the peptide structure that may enhance its bioactivity or stability. Peptides like HMB-Val-Ser-Leu-VE are often studied for their potential benefits in promoting muscle growth, reducing muscle breakdown, and improving overall athletic performance. The presence of branched-chain amino acids (BCAAs) such as valine and leucine suggests that it may play a role in protein synthesis and energy production during exercise. Additionally, the unique structure may influence its solubility, absorption, and efficacy in biological systems. As with many peptides, research is ongoing to fully understand its mechanisms of action and potential therapeutic applications.

HMB-Val-Ser-Leu-VE

862891-04-1: HMB-Val-Ser-Leu-VE, with the CAS number 862891-04-1, is a synthetic peptide that is a derivative of β-hydroxy β-methylbutyrate (HMB), which is known for its role in muscle metabolism and recovery. This compound is characterized by its specific amino acid sequence, which includes valine (Val), serine (Ser), leucine (Leu), and a variant of the peptide structure that may enhance its bioactivity or stability. Peptides like HMB-Val-Ser-Leu-VE are often studied for their potential benefits in promoting muscle growth, reducing muscle breakdown, and improving overall athletic performance. The presence of branched-chain amino acids (BCAAs) such as valine and leucine suggests that it may play a role in protein synthesis and energy production during exercise. Additionally, the unique structure may influence its solubility, absorption, and efficacy in biological systems. As with many peptides, research is ongoing to fully understand its mechanisms of action and potential therapeutic applications.

N-(3-Hydroxy-2-methylbenzoyl)-L-valyl-N-[(1S,2E)-4-ethoxy-1-(2-methylpropyl)-4-oxo-2-butenyl]-L-serinamide is an inhibitor of the ubiquitin proteasome pathway. The enzyme that catalyzes the ATPase reaction of the proteasome is inhibited by N-(3-hydroxy-2 methylbenzoyl)-L valyl -N-[(1S,2E) 4 ethoxy 1 (2 methylpropyl) 4 oxo 2 butenyl] L serinamide. This inhibition prevents the degradation of intracellular proteins and results in cell death. N-(3 hydroxy 2 methylbenzoyl)-L valyl -N-[(1S,2E) 4 ethoxy 1 (2 methylpropyl) 4 oxo 2 butenyl] L serin

CAS 862891-04-1

HMB-Val-Ser-Leu-VE

N-(3-Hydroxy-2-methylbenzoyl)-L-valyl-N-[(1S,2E)-4-ethoxy-1-(2-methylpropyl)-4-oxo-2-butenyl]-L-serinamide

Ref: 3D-MJB89104